Latest News

FDA approves antibody to protect infants from RSV

By Brenda Goodman, CNN Updated 2:42 PM EDT, Mon July 17, 2023

Mom tells how infant son fought for his life because of RSV infection.

(CNN) — This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a year old in the United States every year.

The US Food and Drug Administration approved nirsevimab to protect newborns from respiratory syncytial virus, or RSV, on Monday.

Click here for the rest of this article.